688578.SHG Shanghai Allist Pharmaceuticals Co. Ltd. A

Healthcare Biotechnology Shanghai Stock Exchange
85.99 CNY
Close of Nov 4, 2026
75.55 137.54
Market cap
CNY 38.7B
P/E
12.9x
P/B
4.18x
ROE
34.8%
Dividend yield
0.93%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 688578.SHG undervalued?

Graham number
Price85.99
Graham value55.66
Premium54.5%

688578.SHG trades 54.5% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Shanghai Allist Pharmaceuticals Co. Ltd. A fundamental analysis

No fundamental analysis for Shanghai Allist Pharmaceuticals Co. Ltd. A yet.

Shanghai Allist Pharmaceuticals Co. Ltd. A stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Shanghai Allist Pharmaceuticals Co. Ltd. A

Shanghai Allist Pharmaceuticals Co., Ltd., a pharmaceutical company, engages in the research and development of tumor-targeted drugs in China in internationally. The company's lead product is vometinib mesylate tablet for the treatment of patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer (NSCLC). It also develops pralatinib capsules, as well as glerexyl citrate tablets for treating adult patients with locally advanced or metastatic N…

Full company profile